Neuroendocrine neoplasia goes molecular — time for a change

Neuroendocrine neoplasia goes molecular — time for a changeNeuroendocrine neoplasia goes molecular — time for a change, Published online: 02 November 2018; doi:10.1038/s41571-018-0118-8In a cohort of 100 patients with neuroendocrine cancer, the use of NETest enabled earlier prediction of tumour progression and resulted in a reduction in the frequency of follow-up procedures. These outcomes are exciting and promising, but limited in value by the heterogeneity of the study cohort and by suboptimal assay sensitivity and specificity.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research